NGS Pre-Analytics


Infographic on NGS clinical research milestones

DNA mutations have been implicated in several diseases, particularly cancer, and NGS presents an ideal technology to efficiently profile the multitude of mutations in a high-throughput manner. In 2001 the first draft of human genome was published. Since then many major milestones have been achieved. Do you know when PIK3CA mutations were identified in colon cancer?… Read article →


A needle prick can reveal a lot more today: a view on liquid biopsy and next-generation sequencing

Liquid biopsy is traditionally defined as a non-invasive blood test that detects circulating tumor cells or cell-free DNA (cfDNA) released by tumors into the bloodstream (1). Liquid biopsy enables clinicians to characterize tumors frequently over a long period of time without the need for tissue biopsy. The critical question that often comes up is the… Read article →


Digital RNA sequencing explained:  a new webinar by Dr. Eric Lader

RNA sequencing uses high-throughput DNA sequencing technology to map and quantify transcriptomes and isoforms. So what is digital RNA sequencing? How does it differ from standard RNA sequencing? What are its applications? In this webinar, “Introduction to digital RNA sequencing,” Dr. Eric Lader walks us through the history of transcriptome profiling techniques, starting from Northern blot,… Read article →


QIAGEN launches targeted RNA panels for digital RNA sequencing

Sample to Insight workflows deliver more efficient, accurate gene expression profiling On Monday, we announced the upcoming launch of QIAGEN’s new QIAseq Targeted RNA Panels for digital RNA sequencing. Today, we officially roll out more than 170 new targeted RNA panels for digital RNAseq that allows researchers to accurately quantify transcripts at single copy resolution…. Read article →